{"name":"Resverlogix Corp","slug":"resverlogix-corp","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxOVDlUaWljUHVZQnpsZFFUNm1RaUxRREFfSmlzdkxRa1gyUkJoVW9HaGo4Z2M5elJIWU9PUzBLazdLRmhCQUJ1WUdQdzFtRDhtbGNKekpydVBaVVl0ZE5TY3BuWkJJV1V1NFNIbGl6bWRMNUs5eDZkUURzbV9vVjdRNFIxVEZTU1NzWGRBSklVQ3l5bTdnUDJPb0lsXzh0S0k?oc=5","date":"2026-03-09","type":"trial","source":"openPR.com","summary":"Vascular Dementia Clinical Trial Pipeline Expands as 11+ Pharma - openPR.com","headline":"Vascular Dementia Clinical Trial Pipeline Expands as 11+ Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE1jVkxTWmRQM0lRd1haUThnTXZfb2Y4QWRKVWdZYTZ2dDVjTnktSWhXVDFTZHotd2UwcllManBYd3BIby10MElEMEt6Z3BKcU15UFBUOUFHS0FVMS03SzZrR0E0WXNaQ3BZdUE?oc=5","date":"2025-11-21","type":"pipeline","source":"Precedence Research","summary":"Epigenetic Drugs Market Size to Hit USD 80.81 Billion by 2034 - Precedence Research","headline":"Epigenetic Drugs Market Size to Hit USD 80.81 Billion by 2034","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxNOWZFRzNRdkNQZm1TUkFPa0w5cnJRbk9QVU43dTRWd21PYTU5b0xKaEV6OEhxNXJLblA1Rmd4VUJPdEFnLVo2c1lrWkhoZDJKdlJUV2tBSk91THZhUVdQZTloaFdSOEFXeGNORnczR0JCYnlLbXJCWExTVFRCT0EyYkVHOEJkZw?oc=5","date":"2025-04-11","type":"pipeline","source":"Future Market Insights","summary":"Vascular Dementia Treatment Market 2025 to 2035 - Future Market Insights","headline":"Vascular Dementia Treatment Market 2025 to 2035","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxPbGNUQnBFX3BWVV9UYkZaZkRsRmlTZkF3Sk1pMnFRVUxHbmpWZWlPNDREMXY3SE9wNHA0NU1QVTgxWU5OOXBIZWtsWFBPdjczZFktcWxkRGhVSXlQSE1YS3JqaUJjRjFVYmdIalhXbHdxTkdveS13RjRUV3o3QmowZTdjLUNUbU5uUnBvMVBwYTkzNG1CbnlBZ2FGb2ZmalRVemhBTG0yX0s3T2J3VU8zdHBzYVpxaHFBS2w1WURYQ0JkZmFjX0FrZm4zU1BVRi1vSF9kSmpDUjBDM3hoS2JSUzVKVQ?oc=5","date":"2025-02-13","type":"pipeline","source":"PR Newswire","summary":"Global Artificial Kidney Market to Show Positive Growth at a CAGR of ~13% by 2032 | DelveInsight - PR Newswire","headline":"Global Artificial Kidney Market to Show Positive Growth at a CAGR of ~13% by 2032 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigJBVV95cUxQX1VuWmh5WWpPdWtKbXdKTVN0U2dlSXpDSmpRQ1pWR0l4SlRjN0dKamhCd0w5Zmk5V0pXSE4wOU8xRXNlQnY0cUpnalB0ejdfTE4tSmlPelVEQTdnZGFaemlWYXdZZmJzUndieUFGTmdVT3BhYWdMaVV2RU1iQ0tkUDRyb01hMWZqcDNKa0EzLXd6LVhDeDNlR2FlUThQVTc4TWFKdU1OSU1GUGpfZjBCRmZwMmhYMmJHMl9lMnJOdVpwWEZIaUFQT3RTZHJBSmtRTW5SRTlXa24yejlRQlozcklNWV9zS1hQQmRBZDJRdVRzZTdZVGpVMnZQaFZ6M0pDc1NDOHIycTQ5QQ?oc=5","date":"2023-09-26","type":"pipeline","source":"PR Newswire","summary":"Atherosclerotic Cardiovascular Disease Market to Observe Impressive Growth at a CAGR of 2.2% by 2032, Predicts DelveInsight - PR Newswire","headline":"Atherosclerotic Cardiovascular Disease Market to Observe Impressive Growth at a CAGR of 2.2% by 2032, Predicts DelveInsi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiT0FVX3lxTE16dDFENGtpNnBYUTdVNUUwdTNveTRfRTIwMFNMX20zMjVORk5oX0o0S1d0dnFSZ1ltRDBLSDRlRWNaaldpdTUyX0pXQ1lMLTg?oc=5","date":"2022-09-30","type":"pipeline","source":"Stock Titan","summary":"Latest RVXCF News - Resverlogix Corp. Announces Issuance of MC... - Stock Titan","headline":"Latest RVXCF News - Resverlogix Corp. Announces Issuance of MC...","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingJBVV95cUxQOGtTV21Ec25WMUlpMHU1cGtoZ0puWkw2ajB1MVJ2TTRmYkd2eTZsZGU4Y2M4RHlLeHlIN2lWNXR2ZUZ3NlZMeUlWLUNCUWtIX2RsVU5fcWxyMHRTdEdoVWo1TUQtOXdyV2tZaEdYVkFWNlIxNU9CSFR5bS1ITy00dzhIaGMwNVRpT0VrNGJpZERoZGUwQmhGYjU0dEtkUGJnMmJLajMwYTA1SUxoMU0zT0hKZ08teDlObGJydENNY1ZrZmJ1a2lqVm9Fc1lKcm9OVWVzSVlZeG04M1FKNURPSnNzb0ZqWThLWUJJWWhOcmhTNDJUN2tHTThYNG5LaGFJdnRWRzVqcW1Sa2lDd2VudHBUbHozbHNXQ1QxcEhn?oc=5","date":"2022-04-07","type":"trial","source":"PR Newswire UK","summary":"Vascular Dementia Market Is Contemplated to Surge at a CAGR of 4.05% in the 7MM for the Study Period of 2019-2032, Estimates DelveInsight - PR Newswire UK","headline":"Vascular Dementia Market Is Contemplated to Surge at a CAGR of 4.05% in the 7MM for the Study Period of 2019-2032, Estim","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxQMnpaT0FxVGxCVFFwUDJVaXJNVGk2WTlpVXRFOGx5Mm9BdWpwUHZ3UDk1TFlCT0F6aHg5dnVzOTdLZlRCYlVsVE8weEVmUXAtSi1LZzhOa2tIYTllS3pvTkFmLTFsTllXQjFtTmRXbV95MGplUnBQbXZTbW9ORmo3MXplM0o0RXFnT3BSRHpjQzJxc0RGY3RR?oc=5","date":"2021-11-01","type":"pipeline","source":"Yahoo Finance","summary":"Resverlogix In Active Discussions With The Kingdom of Morocco’s Ministry of Health For The Launch Of COVID-19 Clinical Studies With First-In-Class Drug Apabetalone - Yahoo Finance","headline":"Resverlogix In Active Discussions With The Kingdom of Morocco’s Ministry of Health For The Launch Of COVID-19 Clinical S","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiTkFVX3lxTE94Z2xERl9SZklYWUlUanVzSU04Rm9rd0RFTWI4emJrcDVKZGNfR1pKcFZZamM2VVNqczZmbGlRZU9tZnhtU3VFeXdXeDJRdw?oc=5","date":"2021-09-17","type":"pipeline","source":"The Motley Fool","summary":"MediPharm Labs - MEDIF - Stock Price & News - The Motley Fool","headline":"MediPharm Labs - MEDIF - Stock Price & News","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPSHRXMFdFWWxBN0JtcXdjLXRlOWpVX1VqM2JXVmhpdm84T0xFeUo2aDg4WDRENnltajcwWTJ0aUJJNy0zaGYxbkJUN0dkSm0wbkNXVkNEeXpYNDk1SHZTU2ExdTJ4V0VkQWZvQzg1enlWZDU0ZktOY19UOFFObzlWRWdvWHBqMjFEZ2QzQ1pVaTlrNXVnZkR3QWFzNC1XU21HSmpjY0lB?oc=5","date":"2017-01-26","type":"trial","source":"dicardiology.com","summary":"Resverglogix Study Examines Atherosclerotic Plaque Regression Drug - dicardiology.com","headline":"Resverglogix Study Examines Atherosclerotic Plaque Regression Drug","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}